Fundraising Fox

Imagenomix

2 known investors

Imagenomix develops AI recognition software that infers cancer genetics from pathology slide images, providing molecular diagnostic information in minutes rather than weeks. It targets oncologists and hospitals to expand access to affordable genomic testing and targeted therapy for cancer patients.

AI & Machine LearningBiotechDigital Health

Investors · 2

Modi VenturesHouston
Verge HealthTech FundSingapore · $500K – $1.5M

Funding

SEC filings, press & company announcements

Source: company announcements and press reports — follow each round's link for the claim.

In the news

Cancer Diagnostics Startup Imagenomix Raises $3.2M in Seed Funding | GenomeWebgenomeweb.com · May 2026New Startup Imagenomix Launches to Improve Access to Cancer Testing - Technology Opportunities & Ventures by NYU and NYU Langone Healthtov.med.nyu.edu · Apr 2024

Frequently asked questions

What does Imagenomix do?
Imagenomix develops AI recognition software that infers cancer genetics from pathology slide images, providing molecular diagnostic information in minutes rather than weeks. It targets oncologists and hospitals to expand access to affordable genomic testing and targeted therapy for cancer patients.
Who are Imagenomix's investors?
Imagenomix's investors include Modi Ventures, Verge HealthTech Fund.